We are launching the new era of Alzheimer's prevention research. With more than 35 million people suffering worldwide, Alzheimer's disease is an unacceptable problem with an catastrophic toll. We need to find effective ways to reduce the risk of developing symptoms or prevent it as quickly as possible. The Alzheimer’s Prevention Initiative is intended to do just that. It is our belief that the gre
atest roadblocks to ending Alzheimer's are current scientific methods, funding mechanisms and public policies that need to be put in place to allow us to evaluate the most promising prevention therapies as quickly as possible. This effort is being led by Eric Reiman, MD, and Pierre Tariot, MD, from the Banner Alzheimer's Institute, in collaboration with the Arizona Alzheimer's Consortium (link to page) and other academic, scientific and industry partners around the world. The Alzheimer's Prevention Initiative plans to study the most promising Alzheimer's treatments in people at highest risk of Alzheimer’s in prevention trials.